Age: 27
Free Agency: 2026 (UFA)
Accrued Seasons: 5
- Height: 6'5"
- Weight: 240
- College: Florida Atlantic
- Entry: 2020 Draft, Round 4, #116 overall (Jaguars)
- 2025 Salary Cap Charge: $1,197,500 (0.35% of cap)
- 2025 Cash Payout: $1,337,500 (0.57% of spending)
- 2025 Cash to Cap Ratio: 1.12
- Contract Value: $1,337,500 ($1,337,500 APY)
- Fully Guaranteed Money: $1,172,500
- Contract Ranking: 46/96 at LT
Current Contract
(UFA, signed 2025)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Signing Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 27 | $1,170,000 | $142,500 | $25,000 | $1,030,000 | $1,197,500 | 0.4% | |||||
| Total | $1,170,000 | $142,500 | $25,000 | $1,030,000 | $1,197,500 | |||||||
Cash Flows
- fully earned money
- unearned or partially earned money
$1.3M
| 2025 | |
|---|---|
| Cash Due | $1,337,500 |
| Running Cash | $1,337,500 |
Career Earnings: $6,239,179
Career APY: $1,247,836
Potential Earnings: $5,876,668
Total Guarantees: $2,238,512
Largest Cash Payment: $1,373,612 (2020)
Largest Cap Number: $1,197,500 (2025)
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Jaguars | Drafted | Terminated | 2020 | 4 | $4,058,612 | $1,014,653 | $763,612 | $3,048,612 | 75.1% | $1,016,204 |
| Jaguars | Practice | Terminated | 2023 | 1 | $216,000 | $216,000 | $0 | $0 | 0.0% | $0 |
| 49ers | SFA | Expired | 2023 | 1 | $940,000 | $940,000 | $0 | $365,556 | 38.9% | $365,556 |
| 49ers | UFA | Terminated | 2024 | 1 | $1,125,000 | $1,125,000 | $302,400 | $0 | 0.0% | $0 |
| 49ers | SFA | Expired | 2024 | 1 | $1,125,000 | $1,125,000 | $0 | $1,125,000 | 100.0% | $1,125,000 |
| 49ers | UFA | Active | 2025 | 1 | $1,337,500 | $1,337,500 | $1,172,500 | $142,500 | 10.7% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Jaguars | 3 | $4,303,723 | $1,434,574 | $2,857,709 | 0.0% | $1,446,014 | 0.0% |
| 49ers | 2 | $1,935,456 | $967,728 | $1,350,556 | 0.0% | $302,400 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | Jaguars | $610,000 | $190,903 | $0 | $0 | $800,903 | 0.4% | $1,373,612 | ||
| 2021 | Jaguars | $780,000 | $190,903 | $0 | $0 | $970,903 | 0.5% | $780,000 | ||
| 2022 | Jaguars | $895,000 | $190,903 | $0 | $0 | $1,085,903 | 0.5% | $895,000 | ||
| 2023 | 49ers | $940,000 | $0 | $0 | $0 | $365,556 | 0.2% | $365,556 | ||
| 2024 | 49ers | $1,125,000 | $0 | $0 | $0 | $985,000 | 0.3% | $1,125,000 | ||
| 2025 | 49ers | $1,170,000 | $142,500 | $25,000 | $1,030,000 | $1,197,500 | 0.4% | $1,337,500 | ||
| Total | $5,520,000 | $715,209 | $25,000 | $1,030,000 | $5,405,765 | $5,876,668 | ||||
Statistics
| Year | Games Played | Games Inactive | Snaps | ||
|---|---|---|---|---|---|
| Injured | Healthy | Offense | Special | ||
| 2020 | 13 | 0 | 0 | 21.1% | 10.7% |
| 2021 | 15 | 0 | 0 | 65.2% | 9.1% |
| 2022 | 5 | 0 | 0 | 26.1% | 4.5% |
| 2023 | 13 | 0 | 2 | 20.9% | 13.7% |
| 2024 | 3 | 0 | 10 | 6.0% | 1.1% |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $1,490,000 | $1,337,500 |
| Injury Adjusted | $1,490,000 | $1,337,500 |
test
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.